David Windley
Stock Analyst at Jefferies
(3.59)
# 856
Out of 5,032 analysts
197
Total ratings
67.86%
Success rate
13.33%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $317 → $409 | $356.60 | +14.69% | 27 | Oct 17, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $528.07 | -14.78% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $204.55 | +10.00% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $185.09 | -5.45% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $9.45 | +0.53% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $178.52 | +9.23% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $240.21 | +9.49% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.84 | +49.46% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $35.27 | +72.95% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $19.39 | -38.11% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $419 → $253 | $275.01 | -8.00% | 18 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $299.27 | +41.01% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $192.68 | +54.14% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $1.32 | +184.09% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $348.77 | +73.18% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $446.13 | -15.94% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $16.16 | -4.08% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $283.73 | -4.84% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $11.97 | +29.49% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $270.60 | +98.08% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $24.44 | +18.66% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $8.53 | +2,807.39% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.59 | - | 5 | Oct 9, 2017 |
UnitedHealth Group
Oct 17, 2025
Maintains: Buy
Price Target: $317 → $409
Current: $356.60
Upside: +14.69%
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $528.07
Upside: -14.78%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $204.55
Upside: +10.00%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $185.09
Upside: -5.45%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $9.45
Upside: +0.53%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $178.52
Upside: +9.23%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $240.21
Upside: +9.49%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.84
Upside: +49.46%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $35.27
Upside: +72.95%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $19.39
Upside: -38.11%
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $275.01
Upside: -8.00%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $299.27
Upside: +41.01%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $192.68
Upside: +54.14%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.32
Upside: +184.09%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $348.77
Upside: +73.18%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $446.13
Upside: -15.94%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $16.16
Upside: -4.08%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $283.73
Upside: -4.84%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $11.97
Upside: +29.49%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $270.60
Upside: +98.08%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $24.44
Upside: +18.66%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $8.53
Upside: +2,807.39%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.59
Upside: -